{"id":453131,"title":"Incorporation by Reference List #1: List of new drugs for expanded indication in relation to the COVID-19 pandemic  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-04","captureTimestamp":"2026-01-04T03:48:42.035000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/expanded-indication.html?wbdisable=false","snippet":"List of new drugs for expanded indication in relation to the COVID-19 pandemic Under the interim order , the Minister of Health may permit the sale of a previously approved new drug for a new indication (use) that has not yet been authorized in Canada. The manufacturer does not…","rawSnapshotUrl":"/api/snapshots/raw/453131","browseUrl":"https://replay.healtharchive.ca/job-6/20260104034842/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/expanded-indication.html?wbdisable=false#ha_snapshot=453131","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}